Capstone Investment Advisors
TMDX icon

Capstone Investment Advisors’s Transmedics TMDX Stock Holding History

Capstone Investment Advisors’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,943
Closed -$358K – 1845
2025
Q4 		$358K Buy
2,943
+599
+26% +$75.2K ﹤0.01% 1273
2025
Q3 		$263K Buy
+2,344
New +$274K ﹤0.01% 1701

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capstone Investment Advisors's TMDX Position: Q1 2026 in Review

Capstone Investment Advisors sold out of Transmedics (TMDX) in Q1 2026, closing a stake of 2,943 shares — an estimated $358K sold.

Capstone Investment Advisors first reported a position in TMDX in Q3 2025 and held it in 2 quarters. The position peaked at $358K in Q4 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Capstone Investment Advisors reported no remaining Transmedics position as of Q1 2026 after selling out during the quarter.
  • Capstone Investment Advisors sold 2,943 Transmedics shares in Q1 2026, an estimated $358K.
  • Capstone Investment Advisors first reported a position in Transmedics in Q3 2025 and held it in 2 quarters.
  • Capstone Investment Advisors's Transmedics position peaked at $358K in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.